Consequently, we propose an innovative mechanism whereby ENO1 increases the levels of cytoplasmic glycolytic intermediates (ATP and lactate) to cooperatively regulate these two energy-responsive growth signaling pathways, thereby sustaining tumor progression. Here, ENO1 is linked to neoplasm.